186 related articles for article (PubMed ID: 11740395)
1. Transforming growth factor-beta1 and tumor growth factor-beta-inducible gene-H3 in nonrenal transplant cyclosporine nephropathy.
Langham RG; Egan MK; Dowling JP; Gilbert RE; Thomson NM
Transplantation; 2001 Dec; 72(11):1826-9. PubMed ID: 11740395
[TBL] [Abstract][Full Text] [Related]
2. Renal expression of transforming growth factor-beta inducible gene-h3 (beta ig-h3) in normal and diabetic rats.
Gilbert RE; Wilkinson-Berka JL; Johnson DW; Cox A; Soulis T; Wu LL; Kelly DJ; Jerums G; Pollock CA; Cooper ME
Kidney Int; 1998 Oct; 54(4):1052-62. PubMed ID: 9767521
[TBL] [Abstract][Full Text] [Related]
3. Sodium depletion enhances fibrosis and the expression of TGF-beta1 and matrix proteins in experimental chronic cyclosporine nephropathy.
Shihab FS; Andoh TF; Tanner AM; Bennett WM
Am J Kidney Dis; 1997 Jul; 30(1):71-81. PubMed ID: 9214404
[TBL] [Abstract][Full Text] [Related]
4. Anti-transforming growth factor antibody at low but not high doses limits cyclosporine-mediated nephrotoxicity without altering rat cardiac allograft survival: potential of therapeutic applications.
Khanna AK; Plummer MS; Hilton G; Pieper GM; Ledbetter S
Circulation; 2004 Dec; 110(25):3822-9. PubMed ID: 15583082
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy.
Shihab FS; Bennett WM; Tanner AM; Andoh TF
Kidney Int; 1997 Sep; 52(3):660-73. PubMed ID: 9291185
[TBL] [Abstract][Full Text] [Related]
6. Effect of FTY720 on chronic cyclosporine nephropathy in rats.
Kim JY; Lim SW; Li C; Kim JS; Ahn KO; Yang HJ; Choi BS; Kim YS; Kim J; Bang BK; Yang CW
Transplantation; 2005 Nov; 80(9):1323-30. PubMed ID: 16314802
[TBL] [Abstract][Full Text] [Related]
7. Expression of transforming growth factor-beta-inducible gene-h3 in normal and cyclosporine-treated rat kidney.
Sun BK; Li C; Lim SW; Jung JY; Lee SH; Kim IS; Kim YS; Kim J; Bang BK; Yang CW
J Lab Clin Med; 2004 Mar; 143(3):175-83. PubMed ID: 15007308
[TBL] [Abstract][Full Text] [Related]
8. Intragraft messenger RNA expression of angiotensinogen: relationship with transforming growth factor beta-1 and chronic allograft nephropathy in kidney transplant patients.
Mas V; Alvarellos T; Giraudo C; Massari P; De Boccardo G
Transplantation; 2002 Sep; 74(5):718-21. PubMed ID: 12352892
[TBL] [Abstract][Full Text] [Related]
9. Captopril enhances transforming growth factor (TGF)-beta1 expression in peripheral blood mononuclear cells: a mechanism independent from angiotensin converting enzyme inhibition? A study in cyclosporine-treated kidney-transplanted patients.
Di Paolo S; Schena A; Stallone G; Grandaliano G; Soccio M; Cerullo G; Gesualdo L; Paolo Schena F
Transplantation; 2002 Dec; 74(12):1710-5. PubMed ID: 12499886
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta(1) in the kidney and urine of patients with glomerular disease and proteinuria.
Goumenos DS; Tsakas S; El Nahas AM; Alexandri S; Oldroyd S; Kalliakmani P; Vlachojannis JG
Nephrol Dial Transplant; 2002 Dec; 17(12):2145-52. PubMed ID: 12454225
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of tea polyphenols on transforming growth factor-beta1 expression in rat with cyclosporine A-induced chronic nephrotoxicity.
Shi SH; Zheng SS; Jia CK; Zhu YF; Xie HY
Acta Pharmacol Sin; 2004 Jan; 25(1):98-103. PubMed ID: 14704129
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of cyclosporin and tacrolimus on the expression of fibrosis-associated genes in isolated glomeruli from renal transplants.
Bicknell GR; Williams ST; Shaw JA; Pringle JH; Furness PN; Nicholson ML
Br J Surg; 2000 Nov; 87(11):1569-75. PubMed ID: 11091247
[TBL] [Abstract][Full Text] [Related]
13. Molecular and structural consequences of early renal allograft injury.
Baboolal K; Jones GA; Janezic A; Griffiths DR; Jurewicz WA
Kidney Int; 2002 Feb; 61(2):686-96. PubMed ID: 11849412
[TBL] [Abstract][Full Text] [Related]
14. Urinary transforming growth factor-beta-induced gene-h3 (betaig-h3) as a sensitive predictor in chronic cyclosporine nephrotoxicity.
Kim CD; Cho YJ; Park SH; Ha SW; Lee EG; Kim YJ; Kwon TH; Kim IS; Kim YL
Transplant Proc; 2006 Jun; 38(5):1314-9. PubMed ID: 16797290
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta1 expression in renal allograft rejection and cyclosporine A toxicity.
Ozdemir BH; Ozdemir FN; Demirhan B; Haberal M
Transplantation; 2005 Dec; 80(12):1681-5. PubMed ID: 16378061
[TBL] [Abstract][Full Text] [Related]
16. Urinary transforming growth factor-beta1 excretion in renal allograft recipients during the early post-transplantation period.
Goumenos DS; Tsakas S; Karavias D; Savidaki I; Karatzas T; Vlachojannis JG
Ren Fail; 2003 Jul; 25(4):561-8. PubMed ID: 12911160
[TBL] [Abstract][Full Text] [Related]
17. Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity.
Khanna A; Plummer M; Bromberek C; Bresnahan B; Hariharan S
Kidney Int; 2002 Dec; 62(6):2257-63. PubMed ID: 12427154
[TBL] [Abstract][Full Text] [Related]
18. Expression of transforming growth factor-beta1 and hypoxia-inducible factor-1alpha in an experimental model of kidney transplantation.
Lario S; Mendes D; Bescós M; Iñigo P; Campos B; Alvarez R; Alcaraz A; Rivera-Fillat F; Campistol JM
Transplantation; 2003 May; 75(10):1647-54. PubMed ID: 12777850
[TBL] [Abstract][Full Text] [Related]
19. Blockade of angiotensin II with losartan attenuates transforming growth factor-beta1 inducible gene-h3 (betaig-h3) expression in a model of chronic cyclosporine nephrotoxicity.
Sun BK; Li C; Lim SW; Choi BS; Lee SH; Kim IS; Kim YS; Bang BK; Yang CW
Nephron Exp Nephrol; 2005; 99(1):e9-16. PubMed ID: 15637465
[TBL] [Abstract][Full Text] [Related]
20. TGF-beta1 mRNA upregulation influences chronic renal allograft dysfunction.
Pribylova-Hribova P; Kotsch K; Lodererova A; Viklicky O; Vitko S; Volk HD; Lacha J
Kidney Int; 2006 May; 69(10):1872-9. PubMed ID: 16612332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
